Nanoformulation Strategies for Cancer Treatment 2021
DOI: 10.1016/b978-0-12-821095-6.00008-2
|View full text |Cite
|
Sign up to set email alerts
|

Metallic nanoparticles in drug delivery and cancer treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(4 citation statements)
references
References 96 publications
0
4
0
Order By: Relevance
“…Such nanosystems have been proven to enhance in vivo stability, increase drug accumulation in the tumor site, improve the therapeutic effectiveness of carried drugs, and reduce systemic toxicity. Moreover, they can ensure sustained/programmable or ondemand drug release by responding to internal or external stimuli, respectively [128][129][130].…”
Section: Drug Deliverymentioning
confidence: 99%
“…Such nanosystems have been proven to enhance in vivo stability, increase drug accumulation in the tumor site, improve the therapeutic effectiveness of carried drugs, and reduce systemic toxicity. Moreover, they can ensure sustained/programmable or ondemand drug release by responding to internal or external stimuli, respectively [128][129][130].…”
Section: Drug Deliverymentioning
confidence: 99%
“…Additionally, interest in systems, such as macrocycles, including calix[n]arenes (CXs), cyclodextrins (CDs), cucurbiturils (CBs), and pillararenes is growing 10–14 for their potential as carriers for PBDs, utilizing mechanisms like host–guest complexation or self‐assembly. With the development of nanotechnology, various nanomaterials, such as carbon‐based, lipid‐based, polymer‐based, and metal‐based were increasingly utilized in medical applications and one of the most promising applications of nanotechnology in medicine is the use of nanomaterials for drug delivery 15–21 . Nanomaterials, due to their ability to distinguish between healthy and cancerous cells, can reduce side effects and ensure drug delivery directly to cancer tissues 22,23 .…”
Section: Introductionmentioning
confidence: 99%
“…With the development of nanotechnology, various nanomaterials, such as carbon-based, lipid-based, polymer-based, and metal-based were increasingly utilized in medical applications and one of the most promising applications of nanotechnology in medicine is the use of nanomaterials for drug delivery. [15][16][17][18][19][20][21] Nanomaterials, due to their ability to distinguish between healthy and cancerous cells, can reduce side effects and ensure drug delivery directly to cancer tissues. 22,23 In this regard, graphene-based carbon nanomaterials attracted, recently, considerable attention due to excellent physical, chemical, and biological properties that make them ideal candidate for drug and gene delivery.…”
mentioning
confidence: 99%
“…Mono-, bi-, and poly-metallic nanoparticles (MNPs), or nanoalloys (NAs), find a wealth of potential uses across disciplines ranging from sensing 1,2 to drug-delivery, 3 memory-storage 4,5 to optics 6,7 . Among the most prominent applications, MNPs further play a significant role as thermal, [8][9][10] electro-chemical, 11,12 and photo-chemical 13,14 catalysts.…”
Section: Introductionmentioning
confidence: 99%